Tech Company Financing Transactions
Transcend Therapeutics Funding Round
Transcend Therapeutics closed a $40 million Series A funding round on 2/23/2023. Investors included Alpha Wave Global, Emerald Development Managers and Global Founders Capital.
Transaction Overview
Company Name
Announced On
2/23/2023
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Investors
Proceeds Purpose
The company, which has raised nearly $42M to date, intends to use the funds to launch multiple clinical trials, including a phase II study, with its psychoactive compound.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Fitzroy Square, Adams, House, 3rd Floor,
London, England, W1T 5HE
UK
London, England, W1T 5HE
UK
Phone
Website
Email Address
Overview
Hindawi is one of the world's largest publishers of peer-reviewed, fully open access journals. Our portfolio of more than 220 journals publish open access research across all of the core scientific disciplines, including Engineering and Computer Science & Biosciences. The portfolio includes all 15 journals of the Wiley-Hindawi Partnership together with top SCIE indexed journals, such as Oxidative Medicine and Cellular Longevity, Mathematical Problems in Engineering, Journal of Oncology, BioMed Research International and Advances in High Energy Physics.
Management Team
Browse more venture capital transactions:
Prev: 2/23/2023: Mappedin venture capital transaction
Next: 2/23/2023: Huma venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs